Perneger T V, Sudre P, Lundgren J D, Hirschel B
Institute of Social and Preventive Medicine, University of Geneva, Switzerland.
BMJ. 1995 Dec 2;311(7018):1468-71. doi: 10.1136/bmj.311.7018.1468.
To assess the impact of tuberculosis on mortality in patients with AIDS.
Community based cohort study.
52 centres in 17 countries (AIDS in Europe study).
5249 patients who were alive and free of tuberculosis one month after the diagnosis of AIDS, enrolled between 1979 and 1989, and followed up until 1992.
Onset of clinically active tuberculosis or death, or both.
During a mean follow up period of 15 months 201 (4%) patients developed tuberculosis and 3889 (74%) died. Patients who developed tuberculosis survived significantly longer (median 22 months) than those who did not (median 16 months). This apparent survival advantage was due to patients who survived longer having more opportunity to develop tuberculosis (or any other disease). In models that took into account the time at which tuberculosis was diagnosed, the onset of tuberculosis was associated with a significant increase in mortality (adjusted relative hazard of death 1.34; 95% confidence interval 1.12 to 1.60).
The onset of tuberculosis in patients with AIDS predicts a substantial increase in mortality. Whether this increased mortality is directly attributable to the tuberculosis remains uncertain. If the association is causal preventive chemotherapy and aggressive treatment of tuberculosis could improve survival in AIDS.
评估结核病对艾滋病患者死亡率的影响。
基于社区的队列研究。
17个国家的52个中心(欧洲艾滋病研究)。
5249例患者,在诊断为艾滋病后1个月时存活且无结核病,于1979年至1989年入组,并随访至1992年。
临床活动性结核病的发病、死亡或两者兼有。
在平均15个月的随访期内,201例(4%)患者发生了结核病,3889例(74%)死亡。发生结核病的患者存活时间显著长于未发生结核病的患者(中位数分别为22个月和16个月)。这种明显的生存优势是由于存活时间较长的患者有更多机会发生结核病(或任何其他疾病)。在考虑结核病诊断时间的模型中,结核病的发病与死亡率显著增加相关(调整后的死亡相对风险为1.34;95%置信区间为1.12至1.60)。
艾滋病患者发生结核病预示死亡率大幅增加。这种死亡率增加是否直接归因于结核病仍不确定。如果这种关联是因果关系,预防性化疗和积极治疗结核病可能会改善艾滋病患者的生存。